BioSpace News Archive

Business

Ignyta Announces Third Quarter 2017 Company Highlights and Financial Results

For the third quarter of 2017, net loss was $28.6 million, or $0.51 per share, compared with $23.3 million, or $0.56 per share, for the third quarter of 2016.

November 7, 2017
·
11 min read
Business

Inogen Announces Record Third Quarter 2017 Financial Results

Record total revenue of $69.0 million, up 26.8% over the same period in 2016.

November 7, 2017
·
18 min read
Business

Glaukos Corporation Announces Third Quarter 2017 Financial Results

Net sales rose 37% in the third quarter of 2017 to $40.4 million, compared to $29.6 million in the same period in 2016.

November 7, 2017
·
9 min read
Business

Corindus Vascular Robotics Reports Third Quarter 2017 Results

Revenue for the third quarter of 2017 was $2.4 million compared to $0.7 million for the same period in the prior year.

November 7, 2017
·
9 min read
Business

InspireMD Announces Third Quarter 2017 Results; CGuard Revenue Increases 90% Versus Same Period Last Year

Revenue for the third quarter ended September 30, 2017 was $718,000 compared to $469,000 during the same period in 2016.

November 7, 2017
·
18 min read
Business

Invuity Reports 2017 Third Quarter Financial Results

Revenue was $9.6 million in the third quarter of 2017, up 13% from revenue of $8.5 million in the third quarter of 2016 driven by an increase in active accounts. Management estimates that approximately $400,000 in revenue was lost due to the impact of hurricanes.

November 7, 2017
·
10 min read
Genetown

Sarepta Therapeutics Announces Proposed Offering of $375 Million of Convertible Senior Notes Due 2024

The notes will be offered and sold only to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

November 7, 2017
·
6 min read
Business

Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results

Navidea reported total revenues for the quarter of $224,000.

November 7, 2017
·
12 min read
Business

Invacare Reports Results for Third Quarter 2017

Reported net sales decreased 6.4% to $250.9 million compared to the third quarter last year.

November 7, 2017
·
24 min read
Policy

Caris Life Sciences Files Patent Infringement Suit Against Foundation Medicine, Inc.

Caris is seeking damages and other relief for Foundation’s willful infringement of Caris’ patent rights by its FoundationOne, FoundationACT and FoundationOne Heme products.

November 7, 2017
·
2 min read